U.S. stock futures were slightly lower this morning, with the Nasdaq futures falling around 0.1% on Tuesday.
Shares of Medifast, Inc. MED fell sharply in today's pre-market trading after the company reported mixed first-quarter financial results.
Medifast posted adjusted earnings of 66 cents per share, missing market estimates of 78 cents per share. The company's quarterly sales came in at $174.739 million versus expectations of $168.900 million, according to data from Benzinga Pro.
Medifast shares tumbled 15.6% to $29.95 in pre-market trading.
Here are some big stocks recording losses in today's pre-market trading session.
- Coursera, Inc. COUR shares dipped 12.7% to $10.37 in pre-market trading after the company reported mixed first-quarter financial results and issued FY24 revenue guidance below estimates.
- Chegg, Inc. CHGG shares declined 12.1% to $6.30 in pre-market trading after the company posted first-quarter results and named Nathan Shultz as CEO.
- ADC Therapeutics SA ADCT fell 6.7% to $4.20 in pre-market trading. The company, earlier during the month, announced the completion of dose escalation in LOTIS-7, a Phase 1b open-label clinical trial evaluating ZYNLONTA in combination with glofitamab or mosunetuzumab in heavily pre-treated patients with relapsed/refractory B-cell non-Hodgkin lymphoma.
- Mesoblast Ltd MESO shares declined 5.7% to $6.69 in pre-market trading.
- Coeur Mining, Inc. CDE shares fell 5.7% to $4.63 in pre-market trading.
- Prudential plc PUK slipped 5.1% to $17.84 in pre-market trading. Prudential, last month, reported worse-than-expected FY 2023 revenues and earnings.
- Yum China Holdings, Inc. YUMC shares declined 5.1% to $38.00 in pre-market trading. Yum China posted upbeat earnings for its first quarter, while sales missed expectations.
- Sibanye Stillwater Limited SBSW shares fell 5% to $4.82 in pre-market trading.
- Rambus Inc. RMBS shares declined 4.1% to $58.01 in pre-market trading following first-quarter results.
Now Read This: Investor Sentiment Improves Further, Dow Jumps Over 100 Points
Don't forget to check out our premarket coverage here
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.